Knowledge Hub

Effect of booster doses of poliovirus vaccine in previously vaccinated children, Clinical Trial Results 2013

Authors:

Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America

Authors:

Service delivery Polio English IPV bOPV mOPV2 Region of the Americas

Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial

Authors:

Service delivery Polio English IPV bOPV mOPV2 tOPV Region of the Americas

Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh

Authors:

Service delivery Bangladesh Rotavirus Polio English bOPV mOPV1 tOPV South-East Asia Region

Regulatory aspects of Sabin Type 2 withdrawal from trivalent Oral Poliovirus Vaccine: Process and lessons learned

Authors:

Programme management Polio English IPV bOPV mOPV1 mOPV2 mOPV3 tOPV

Systematization of the Introduction of IPV and Switch from tOPV to bOPV in the Americas

Authors:

Programme management English IPV bOPV tOPV Region of the Americas

Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial

Authors:

Service delivery Bangladesh Polio English bOPV mOPV1 South-East Asia Region

Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes

Authors:

Service delivery Polio English bOPV mOPV1 mOPV2 mOPV3 tOPV

Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region

Authors:

Global initiatives Polio English IPV bOPV tOPV African Region

Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial

Authors:

Vaccines & delivery devices Polio English IPV bOPV tOPV

Polio vaccination: past, present and future.

Authors:

Service delivery Polio English IPV bOPV mOPV1 mOPV2 mOPV3 tOPV

P6.3 Two years after the tOPV ot bOPV switch: What happened to Poliovirus Type 2?

Authors:

Ondrej Mach

Global initiatives Polio English bOPV tOPV

Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio

Authors:

Lee M. Hampton et al.

Global initiatives Polio English bOPV mOPV2 tOPV

Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes

Authors:

Service delivery Polio English bOPV mOPV2 tOPV

Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission

Authors:

Service delivery Pakistan Nigeria Polio English Coverage monitoring bOPV mOPV1 mOPV2 mOPV3 tOPV Eastern Mediterranean Region African Region

Monitoring and Validation of the Global Replacement of tOPV with bOPV, April–May 2016

Authors:

Global initiatives Polio English World Health Organization (WHO) SAGE bOPV tOPV

Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization

Authors:

Vaccines & delivery devices Sri Lanka Pakistan India Polio English IPV bOPV mOPV1 tOPV South-East Asia Region Eastern Mediterranean Region

Administering Multiple Injectable Vaccines During a Single Visit—Summary of Findings From the Accelerated Introduction of Inactivated Polio Vaccine Globally

Authors:

Service delivery Polio English New vaccine introduction SAGE IPV bOPV tOPV

Acceptance of the Administration of Multiple Injectable Vaccines in a Single Immunization Visit in Albania

Authors:

Service delivery Albania Polio English IPV bOPV tOPV European Region

Experience With Inactivated Polio Vaccine Introduction and the “Switch” From Trivalent to Bivalent Oral Polio Vaccine in the World Health Organization’s Western Pacific Region

Authors:

Global initiatives Vanuatu Tuvalu Tonga Samoa Nauru Lao People's Democratic Republic Fiji Cook Islands China Cambodia Polio English World Health Organization (WHO) IPV bOPV tOPV Western Pacific Region

Knowledge Hub

Effect of booster doses of poliovirus vaccine in previously vaccinated children, Clinical Trial Results 2013

Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America

Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial

Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh

Regulatory aspects of Sabin Type 2 withdrawal from trivalent Oral Poliovirus Vaccine: Process and lessons learned

Systematization of the Introduction of IPV and Switch from tOPV to bOPV in the Americas

Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial

Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes

Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region

Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial

Polio vaccination: past, present and future.

P6.3 Two years after the tOPV ot bOPV switch: What happened to Poliovirus Type 2?

Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio

Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes

Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission

Monitoring and Validation of the Global Replacement of tOPV with bOPV, April–May 2016

Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization

Administering Multiple Injectable Vaccines During a Single Visit—Summary of Findings From the Accelerated Introduction of Inactivated Polio Vaccine Globally

Acceptance of the Administration of Multiple Injectable Vaccines in a Single Immunization Visit in Albania

Experience With Inactivated Polio Vaccine Introduction and the “Switch” From Trivalent to Bivalent Oral Polio Vaccine in the World Health Organization’s Western Pacific Region

Filters

About

Knowledge Hub

Community

More